Alx Oncology Holdings Inc’s recent filing unveils that its SVP, FINANCE AND CAO Pinto Shelly unloaded Company’s shares for reported $633.0 on Feb 19 ’25. In the deal valued at $1.15 per share,550 shares were sold. As a result of this transaction, Pinto Shelly now holds 87,352 shares worth roughly $68134.56.
Then, Pons Jaume sold 1,326 shares, generating $1,525 in total proceeds. Upon selling the shares at $1.15, the PRESIDENT & CSO now owns 579,388 shares.
Before that, Lettmann Jason sold 2,159 shares. Alx Oncology Holdings Inc shares valued at $2,483 were divested by the CHIEF EXECUTIVE OFFICER at a price of $1.15 per share. As a result of the transaction, Lettmann Jason now holds 170,270 shares, worth roughly $0.13 million.
Jefferies upgraded its Alx Oncology Holdings Inc [ALXO] rating to a Buy from a a Hold in a research note published on March 06, 2025; the price target was increased to $3 from $2. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in mid December from “a Buy” to “a Hold”. Stifel also remained covering ALXO and has decreased its forecast on March 08, 2024 with a “Hold” recommendation from previously “Buy” rating. Jefferies revised its rating on December 08, 2023. It rated ALXO as “a Buy” which previously was an “a Hold”.
Price Performance Review of ALXO
On Monday, Alx Oncology Holdings Inc [NASDAQ:ALXO] saw its stock fall -5.60% to $0.78. Over the last five days, the stock has lost -12.31%. Alx Oncology Holdings Inc shares have fallen nearly -53.08% since the year began. Nevertheless, the stocks have fallen -93.24% over the past one year. While a 52-week high of $17.83 was reached on 01/08/25, a 52-week low of $0.83 was recorded on 03/17/25. SMA at 50 days reached $1.2993, while 200 days put it at $2.8951.
Levels Of Support And Resistance For ALXO Stock
The 24-hour chart illustrates a support level at 0.7471, which if violated will result in even more drops to 0.7105. On the upside, there is a resistance level at 0.8451. A further resistance level may holdings at 0.9065. The Relative Strength Index (RSI) on the 14-day chart is 34.95, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1808, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.41%. Stochastics %K at 4.18% indicates the stock is a buying.
How much short interest is there in Alx Oncology Holdings Inc?
A steep rise in short interest was recorded in Alx Oncology Holdings Inc stocks on 2025-02-28, dropping by -0.1 million shares to a total of 5.89 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 5.99 million shares. There was a decline of -1.72%, which implies that there is a negative sentiment for the stock.
